Brief

On March 22, 2025, the Government of Canada announced support for OmniaBio's expanded facility in Hamilton, Ontario. The project aims to drive a 5X increase in manufacturing efficiency and reduce production costs by up to 50%, facilitating access to life-saving treatments for chronic diseases, including cancer. This initiative aligns with Canada's Biomanufacturing and Life Sciences Strategy and strengthens the country's leadership position in cell and gene therapies.

This content is restricted.

Highlights content goes here...

This content is restricted.

Innovation, Science and Economic Development Canada

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies